Kim KY - Search Results

1

Environment-Sensitive Ectodomain Shedding of Epithin/PRSS14 Increases Metastatic Potential of Breast Cancer Cells by Producing CCL2.

Jang J, Cho EH, Cho Y, Ganzorig B, Kim KY, Kim MG, Kim C. Jang J, et al. Among authors: kim c, kim mg, kim ky. Mol Cells. 2022 Aug 31;45(8):564-574. doi: 10.14348/molcells.2022.2004. Epub 2022 Aug 10. Mol Cells. 2022. PMID: 35950457 Free PMC article.

2

Expression Analyses Revealed Thymic Stromal Co-Transporter/Slc46A2 Is in Stem Cell Populations and Is a Putative Tumor Suppressor.

Kim KY, Lee G, Yoon M, Cho EH, Park CS, Kim MG. Kim KY, et al. Among authors: kim mg. Mol Cells. 2015 Jun;38(6):548-61. doi: 10.14348/molcells.2015.0044. Epub 2015 May 27. Mol Cells. 2015. PMID: 26013383 Free PMC article.

3

Targeting metastatic breast cancer with peptide epitopes derived from autocatalytic loop of Prss14/ST14 membrane serine protease and with monoclonal antibodies.

Kim KY, Yoon M, Cho Y, Lee KH, Park S, Lee SR, Choi SY, Lee D, Yang C, Cho EH, Jeon SD, Kim SH, Kim C, Kim MG. Kim KY, et al. Among authors: kim sh, kim c, kim mg. J Exp Clin Cancer Res. 2019 Aug 19;38(1):363. doi: 10.1186/s13046-019-1373-y. J Exp Clin Cancer Res. 2019. PMID: 31426843 Free PMC article.

4

A JUN N-terminal kinase inhibitor induces ectodomain shedding of the cancer-associated membrane protease Prss14/epithin via protein kinase CβII.

Yoon J, Cho Y, Kim KY, Yoon MJ, Lee HS, Jeon SD, Cho Y, Kim C, Kim MG. Yoon J, et al. Among authors: kim c, kim mg, kim ky. J Biol Chem. 2020 May 15;295(20):7168-7177. doi: 10.1074/jbc.RA119.011206. Epub 2020 Apr 2. J Biol Chem. 2020. PMID: 32241917 Free PMC article.

5

Critical Adjuvant Influences on Preventive Anti-Metastasis Vaccine Using a Structural Epitope Derived from Membrane Type Protease PRSS14.

Kim KY, Cho EH, Yoon M, Kim MG. Kim KY, et al. Among authors: kim mg. Immune Netw. 2020 Aug 18;20(4):e33. doi: 10.4110/in.2020.20.e33. eCollection 2020 Aug. Immune Netw. 2020. PMID: 32895620 Free PMC article.

6

Overexpression of matriptase correlates with poor prognosis in esophageal squamous cell carcinoma.

Ha SY, Kim KY, Lee NK, Kim MG, Kim SH. Ha SY, et al. Among authors: kim sh, kim mg, kim ky. Virchows Arch. 2014 Jan;464(1):19-27. doi: 10.1007/s00428-013-1504-3. Epub 2013 Nov 19. Virchows Arch. 2014. PMID: 24248283

7

Thymic epithelial requirement for γδ T cell development revealed in the cell ablation transgenic system with TSCOT promoter.

Lee G, Kim KY, Chang CH, Kim MG. Lee G, et al. Among authors: kim mg, kim ky. Mol Cells. 2012 Nov;34(5):481-93. doi: 10.1007/s10059-012-0246-4. Epub 2012 Nov 15. Mol Cells. 2012. PMID: 23178972 Free PMC article.

8

Ex vivo expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells through different receptor-ligand interactions.

Jung D, Baek YS, Lee IJ, Kim KY, Jang H, Hwang S, Jung J, Moon YW, Park KS, Choi YS, An HJ. Jung D, et al. Among authors: kim ky. J Exp Clin Cancer Res. 2021 Oct 23;40(1):333. doi: 10.1186/s13046-021-02089-0. J Exp Clin Cancer Res. 2021. PMID: 34686187 Free PMC article.

9

Combined use of cisplatin plus natural killer cells overcomes immunoresistance of cisplatin resistant ovarian cancer.

Choi SH, Jung D, Kim KY, An HJ, Park KS. Choi SH, et al. Among authors: kim ky. Biochem Biophys Res Commun. 2021 Jul 23;563:40-46. doi: 10.1016/j.bbrc.2021.05.066. Epub 2021 May 28. Biochem Biophys Res Commun. 2021. PMID: 34058473

10

Scalable electron tomography for connectomics.

Kuan AT, Phan S, Kim KY, Mackey M, Kim M, Peltier ST, Ellisman M, Lee WA. Kuan AT, et al. Among authors: kim ky. bioRxiv [Preprint]. 2024 Jun 6:2024.06.05.597487. doi: 10.1101/2024.06.05.597487. bioRxiv. 2024. PMID: 38895398 Free PMC article. Preprint.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,003 results

Search Page